Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GILEAD SCIENCES K.K.

Home Clinical Trial Sponsors and OrganizationsGILEAD SCIENCES K.K.

GILEAD SCIENCES K.K.

1-9-2, MARUNOUCHI, Chiyoda-Ku, Tokyo, Japan

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

32

14 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

10

31.3%

Phase 2

2

6.3%

Trial Status Distribution

Active, not recruiting

12

37.5%

Completed

14

43.8%

Not yet recruiting

2

6.3%

Recruiting

4

12.5%

Clinical Trials

Trials sponsored by this organization (32)

A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants with Severe COVID-19

2,400 participants

Study Evaluating the Safety, Tolerability and Efficacy of Cilofexor in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis

400 participants

A Phase 2 Multicenter, Open-label, Single-arm Study of KTE-C19 in Japanese Patients with Refractory or Relapsed Large B Cell Lymphoma

10 participants

Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

130 participants

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01)

520 participants

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy

390 participants

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (EVOKE-SCLC-04)

Not yet recruiting

695 participants

Study of KTE-X19 in Adult Japanese Subjects with Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (JKART-1)

Active, not recruiting

21 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials32
Approvals
News

Back to Organizations